NeurosciencebioRxivPreprint
Morphological profiling by cell painting in human neural progenitor cells classifies hit compounds in a pilot drug screen for Alzheimer's disease
Amina McDiarmid, Katerina Gospodinova, Richard J. R. Elliott…·Kathryn Louise Evans
The paper uses cell painting to identify drugs that reverse SORL1 deletion phenotypes in neural progenitor cells, revealing potential therapeutic targets for Alzheimer's disease.